970
APPENDIX IX
TABLE IX-1 (
con tin u ed
)
Component
Present Reference
Interval
(Examples)
Present
Unit
Conversion
Factor
SI
Reference
Interval
SI Unit
Symbol
Significant
Digits
Suggested
Minimum
Increment
Coproporphyrins (U)
<200
Mg/24 h
1.527
<300
nmol/d
xxo
10 nmol/d
Corticol (S)
0800 h
4-19
JUg/dL
27.59
110-520
nmol/L
xxo
10 nmol/L
1600 h
2-15
Mg/dL
27.59
50-410
nmol/L
xxo
10 nmol/L
2400 h
5
Mg/dL
27.59
140
nmol/L
xxo
10 nmol/L
Cortisol, free (U)
10-110
Mg/24 h
2.759
30-300
nmol/d
xxo
10 nmol/d
Creatine (S)
male
0.17-0,50
mg/dL
76.25
10-40
Mmol/L
xo
10 jUmol/L
female
0.35-0.93
mg/dL
76.25
30-70
Mmol/L
xo
10 Mmol/L
Creatine (U)
male
0-40
mg/24 h
7.625
0-300
Mmol/d
xxo
10 Mmol/d
female
0-80
mg/24 h
7.625
0-600
Mmol/d
xxo
10 Mmol/d
Creatine kinase (CK) (S)
0-130
U/L
0.01667
0-2.16
Mkat/L
x .x x
0.01 jUkat/L
Creatine kinase isoenzymes (S)
MB fraction
>5 in myocardial
infarction
%
0.01
>0.05
1
o.xx
0.01
Creatinine (S)
0.6-1.2
mg/dL
88.40
50-110
Mmol/L
xxo
10 Mmol/L
Creatinine (U)
Variable
g/24 h
8.840
Variable
mmol/d
x x .x
0.1 mmol/d
Creatinine clearance (S, U)+
75-125
mL/min
0.01667
1.24-2.08
mL/s
x .x x
0.02 mL/s
Cyanide (B)—lethal
>0.10
mg/dL
384.3
>40
Mmol/L
XXX
5 Mmol/L
Cyanocobalamin (S)
200-1000
pg/mL
0.7378
150-750
pmol/L
xxo
10 pmol/L
(vitamin B12)
Cyclic AMP (S)
2.Ö-6.6
Mg/L
3.038
8-20
nmol/L
x x x
I nmol/L
Cyclic AMP (U)
total urinary
2.9-5.6
jUmol/g créât.
113.1
330-630
nmol/mmol
créât.
xxo
10 nmol/mmol
creatinine
renal tubular
<2.5
/xmol/g créât.
113.1
<280
nmol/mmol
créât.
xxo
10 nmol/mmol
creatinine
Cyclic GMP(S)
0.6-3.5
Mg/L
2.897
1.7-10.1
nmol/L
x x .x
0.1 nmol/L
Cyclic GMP(U)
0.3-1.8
jUmol/g créât.
113.1
30-200
nmol/mmol
créât.
xxo
10 nmol/mmol
creatinine
Cystine (U)
10-100
mg/24 h
4.161
40-420
Mmol/d
xxo
10 Mmol/d
Déhydroépiandrostérone (P, S)
(DHEA)
1—4 y
0.2-0.4
M
g/L
3.467
0.6-1.4
nmol/L
x x .x
0.2 nmol/L
4-8 y
0.1-1.9
Mg/L
3.467
0.4-6.6
nmol/L
x x .x
0.2 nmol/L
8-10 y
0.2-2.9
M
g/L
3.467
0.6-10.0
nmol/L
x x .x
0.2 nmol/L
10-12 y
0.5-9.2
jUg/L
3.467
1.8-31.8
nmol/L
x x .x
0.2 nmol/L
12-14y
0.9-20.0
Mg/L
3.467
3.2-69.4
nmol/L
x x .x
0.2 nmol/L
14-16 y
2.5-20.0
g/L
3.467
8.6-69.4
nmol/L
x x .x
0.2 nmol/L
premenopausal female
2.0-15.0
g/L
3.467
7.0-52.0
nmol/L
x x .x
0.2 nmol/L
male
0.8-10.0
g/L
3.467
2.8-34.6
nmol/L
x x .x
0.2 nmol/L
Dehydroepiandrosterone (see
steroid fractionation) (U)
—
—
—
—
—
—
—
Dehydroepiandrosterone sulfate
(DHEA-S) (P, S)
newborn
1670-3640
ng/mL
0.002714
4.5-9.9
Mmol/L
x x .x
0.1 Mmol/L
prepubertal children
100-600
ng/mL
0.002714
0.3-1.6
Mmol/L
x x .x
0.1 Mmol/L
male
2000-3350
ng/mL
0.002714
5.4-9.1
Mmol/L
x x .x
0.1 Mmol/L
female (premenopausal)
820-3380
ng/mL
0.002714
2.2-9.2
Mmol/L
x x .x
0.1 Mmol/L
female (post-menopausal)
110-610
ng/mL
0.002714
0.3-1.7
Mmol/L
x x .x
0.1 Mmol/L
pregnancy (term)
230-1,170
ng/mL
0.002714
0.6-3.2
Mmol/L
x x .x
0.1 jttmol/L
11
-Deoxycortisol (S)
0-2
Mg/dL
28.86
0-60
nmol/L
xxo
10 nmol/L
Desipramine (P)—therapeutic
50-200
ng/mL
3.754
170-700
nmol/L
xxo
10 nmol/L
Diazepam (P)—therapeutic
0.10-0.25
mg/L
3512
350-900
nmol/L
xxo
10 nmol/L
toxic
>1.0
mg/L
3512
>3510
nmol/L
xxo
10 nmol/L
Dicoumarol (P)—therapeutic
8-30
mg/L
2.974
25-90
Mmol/L
XX
5 Mmol/L
Digoxin (P)—therapeutic
0.5-2.2
ng/mL
1.281
0.6-2.8
nmol/L
x.x
0.1 nmol/L
0.5-2.2
Mg/L
1.281
0.6-2.8
nmol/L
x.x
0.1 nmol/L
toxic
>2.5
ng/mL
1.281
>3.2
nmol/L
x.x
0.1 nmol/L
Dimethadione (P)—
therapeutic
<1.00
g/L
7.745
<7.7
mmol/L
x.x
0.1 mmol/L
